Founded in 1985, National Breast Cancer Awareness Month (BCAM) is celebrated each October with a mission of educating the public about the causes, risks, prevention and detection of breast cancer. With one in eight women developing invasive breast cancer over the course of her lifetime and more than 330,000 new cases being diagnosed every year, it has never been more important to bring attention to breast health. Interestingly, BCAM often assists in lifting the fear of the unknown about breast cancer and opens the door for many frank conversations about the... Continue reading

Results demonstrate unprecedented improvements in clinical performance and reading times, validating the substantial benefits of artificial intelligence when used with 3D mammography

Company to showcase latest innovations in cancer detection at The European Society of Breast Imaging annual meeting in booth 14

NASHUA, N.H. and ATHENS, Greece, (October 11, 2018) – iCAD, Inc. (NASD... Continue reading

Premier center becomes first in the region to offer intraoperative radiation therapy with the leading-edge Xoft System to advance quality patient care in New York State

NASHUA, N.H. and Syracuse, N.Y., (October 9, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that its Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is now available at Upstate Medical University. Affiliated w... Continue reading

Medical facility becomes first in South Dakota to offer intraoperative radiation therapy with the revolutionary Xoft System to improve patient care

NASHUA, N.H. and SIOUX FALLS, S.D., (October 3, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the availability of the company’s Xoft® Axxent®Electronic Brachytherapy (eBx®) System® at Sanford USD Medical Center. The new tr... Continue reading

Retrospective trial utilizing intraoperative radiation therapy with the revolutionary Xoft System shows recurrence rates to be comparable to cornerstone TARGIT-A Trial at mean follow-up 4.6 years

NASHUA, N.H., (October 1, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the results of a long-term, independent study conducted with the Xoft® Axxent® Electronic Brachytherap... Continue reading

First installation of versatile, multi-platform Xoft System in India demonstrates strong, continued momentum in global commercialization of electronic brachytherapy (eBx)

Nashua, N.H. and Hyderabad, India, (August 29, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, announced today that its Xoft® Axxent® Electronic Brachytherapy (eBx®) System® has received an Atomic Energy Regulatory Bo... Continue reading

Leading center becomes first in Texas to offer intraoperative radiation therapy with the advanced Xoft System to enhance patient care

NASHUA, N.H. and Plano, Texas, (August 28, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that its Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is now available at Medical City Plano. Operated by HCA Healthcare, the world-class medical facility in Plano, Texas is the first in the state to offer intraoper... Continue reading

PowerLook Tomo Detection Version 2.0 Submitted for FDA Approval

Conference call today at 4:30 p.m. ET

NASHUA, N.H. (August 14, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology

company providing innovative cancer detection and therapy solutions, today reported financial results for the three and six months ended June 30, 2018.

Second Quarter 2018 Highlights:

Breast Density Assessment Software Built on Artificial Intelligence

Nashua, NH – August 8, 2018 – iCAD (Nasdaq: ICAD), a global leader in medical technology providing innovative cancer detection and therapy solutions, announced today FDA clearance of its latest Artificial Intelligence software solution; PowerLook Density Assessment Version 3.4. The software is compatible with iCAD’s digital breast tomosynthesis (DBT) platform on both GE and Hologic systems, enhancing the Company’s comprehensive... Continue reading

NASHUA, N.H. (August 7, 2018) –  iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that it will release financial results for the second quarter and six months ended June 30, 2018 after the close of the market, and host a conference call at 4:30pm Eastern Time, on Tuesday, August 14th.

Tuesday, August 14th @ 4:30pm Eastern Time

Domest... Continue reading

We’re halfway through 2018, providing us with the perfect opportunity to reflect on the goals we have set for ourselves this year and how we are tracking toward them. At iCAD, our goal is to keep you iNFORMED and aware by sharing tips and resources that are pertinent to your breast health.

And while many individuals set goals and resolutions for themselves each year related to health, there are often other sides of health that get left behind – such as your breast health.

This year alone, an estimated 266,120 new cases of invasive breast cancer are exp... Continue reading

Last month we announced that our digital breast tomosynthesis (DBT) solution – PowerLook Tomo Detection – had been named a finalist for the 2018 Medical Design Excellence Awards (MDEA), the premier awards program for the MedTech industry. Today, we are thrilled to announce continued momentum and additional industry recognition.

iCAD has been selected as the winner of the 2018 MedTech Breakthrough Award in the Best New Technology Solution – Radiology category.

Each year the MedTech... Continue reading

Company’s PowerLook® Tomo Detection Solution Recognized as “Best New Radiology Solution” 

Nashua, NH – June 6, 2018 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that its PowerLook® Tomo Detection solution has been selected as the winner of the “Best New Radiology Solution” award by MedTech Breakthrough, an independent organization recognizing the top companies, technologies and... Continue reading

May 13-19 is National Women’s Health Week and a great opportunity for women to stop, take a breather and remember that putting your own health first will allow you to take better care of your family and loved ones.

This includes staying on top of your breast health.

With about 1 in 8 women in the U.S. being diagnosed with breast cancer in her lifetime, it is the most commonly diagnosed cancer in women. On average, every 2 minutes a woman is diagnosed with breast cancer and 1 woman will die of breast cancer... Continue reading

Company Expects to Submit PowerLook Tomo Detection Version 2.0 for FDA Approval Shortly

Submission to be Based on Promising Results from Pivotal Clinical Reader Study

Conference call today at 4:30 p.m. ET

NASHUA, N.... Continue reading

NASHUA, N.H. (May 8, 2018) – iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that it will release financial results for the first quarter ended March 31, 2018 after the close of the market, and host a conference call at 4:30 pm Eastern Time, on Monday, May 14, 2018.

Monday, May 14th @ 4:30pm Eastern Time

Domestic:

(800... Continue reading

In March of 2017, we announced that our deep learning based digital breast tomosynthesis (DBT) solution – PowerLook Tomo Detection – had received approval from the U.S. Food and Drug Administration (FDA). For those not familiar, PowerLook Tomo Detection is a first-of-its-kind, concurrent-read computer aided detection solution designed to assist radiologists in reading DBT studies. As part of the development for the product, PowerLook Tomo went through a reader study where it showed time savings of 29.2% for a radiologist when reading large data sets without impacting radiolog... Continue reading

Company to showcase advanced, multi-platform electronic brachytherapy (eBx) technology in booth 6800

Nashua, N.H. and Barcelona, Spain (ESTRO Booth 6800) (April 19, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that researchers from Hospital Universitario Miguel Servet in Zaragoza, Spain will present new results from three clinical... Continue reading

Fourth quarter total revenues increased 14% year-over-year; total revenues increased 22% excluding MRI asset sale

Conference call today at 4:30 p.m. ET

NASHUA, N.H. (March 22, 2018) – iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the three and twelve months ended December 31, 2017.

View Webcast
Full Results

Has your healthcare provider ever spoken with you about breast density? Are you aware of the correlation between breast density and breast cancer? If you answered no to either of these questions, we urge you to keep reading.

Research has shown that women with dense breasts can be six times more likely to develop breast cancer; but what exactly does having dense breasts mean, and what can you do if you are one of the more than 40 percent of women in the U.S. with dense breast tissue?

For starters, having dense breasts simply means you... Continue reading